Research Article
In-Vitro Biofilm Formation and Antimicrobial Resistance of Escherichia coli in Diabetic and Nondiabetic Patients
Table 4
Antimicrobial resistance of E. coli isolated from diabetic and nondiabetic patients.
| Antimicrobial agents | Diabetic E. coli () | Nondiabetic E. coli () | -value | Resistance | % | Resistance | % |
| Amikacin | 9 | 14.8 | 11 | 9.8 | 0.332 | Amoxicillin | 55 | 90.2 | 101 | 90.2 | 0.998 | Ciprofloxacin | 42 | 68.9 | 65 | 58 | 0.162 | Ceftriaxone | 33 | 54.1 | 64 | 57.1 | 0.7 | Cotrimoxazole | 38 | 62.3 | 64 | 57.1 | 0.51 | Nitrofurantoin | 7 | 11.5 | 14 | 12.5 | 0.884 | Piperacillin–tazobactum | 23 | 37.7 | 35 | 31.3 | 0.39 | Imipenem | 5 | 8.2 | 8 | 7.1 | 0.802 | Tetracycline | 18 | 29.5 | 33 | 29.5 | 0.995 |
|
|